0NES Stock Overview
Oriola Oyj provides healthcare and wellbeing products primarily in Sweden and Finland.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 2/6 |
Oriola Oyj Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €1.06 |
52 Week High | €1.47 |
52 Week Low | €0.89 |
Beta | 0.60 |
1 Month Change | 7.29% |
3 Month Change | -2.00% |
1 Year Change | -27.49% |
3 Year Change | -45.86% |
5 Year Change | -55.53% |
Change since IPO | -62.28% |
Recent News & Updates
Recent updates
Shareholder Returns
0NES | GB Healthcare | GB Market | |
---|---|---|---|
7D | 0.8% | 1.4% | 2.7% |
1Y | -27.5% | -29.1% | 0.3% |
Return vs Industry: 0NES exceeded the UK Healthcare industry which returned -29.5% over the past year.
Return vs Market: 0NES underperformed the UK Market which returned -1.8% over the past year.
Price Volatility
0NES volatility | |
---|---|
0NES Average Weekly Movement | 3.7% |
Healthcare Industry Average Movement | 7.2% |
Market Average Movement | 4.9% |
10% most volatile stocks in GB Market | 11.3% |
10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: 0NES has not had significant price volatility in the past 3 months.
Volatility Over Time: 0NES's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2006 | 872 | Katarina Gabrielson | oriola.com |
Oriola Oyj provides healthcare and wellbeing products primarily in Sweden and Finland. It also offers vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products. In addition, it provides pharmaceutical logistics and dose dispensing services.
Oriola Oyj Fundamentals Summary
0NES fundamental statistics | |
---|---|
Market cap | €197.39m |
Earnings (TTM) | -€20.70m |
Revenue (TTM) | €1.50b |
0.1x
P/S Ratio-9.3x
P/E RatioIs 0NES overvalued?
See Fair Value and valuation analysisEarnings & Revenue
0NES income statement (TTM) | |
---|---|
Revenue | €1.50b |
Cost of Revenue | €1.33b |
Gross Profit | €161.00m |
Other Expenses | €181.70m |
Earnings | -€20.70m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 25, 2024
Earnings per share (EPS) | -0.11 |
Gross Margin | 10.77% |
Net Profit Margin | -1.38% |
Debt/Equity Ratio | 63.8% |
How did 0NES perform over the long term?
See historical performance and comparison